Death caused by toxic epidermal necrolysis (Lyell Syndrome)

Journal of Forensic Sciences

Volumn 55, Issue 3, 2010, Pages 839-841

  Ventura, Francesco ^a   Fracasso, Tony ^a,b   Leoncini, Andrea ^a   Gentile, Raffaella ^c   De Stefano, Francesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Allopurinol; Burns; Forensic science; Lyell syndrome; Medical liability; Toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL; ANTIGOUT AGENT;

AGED; ARTICLE; CASE REPORT; FATALITY; FEMALE; HUMAN; MULTIPLE ORGAN FAILURE; PATHOLOGY; TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON SYNDROME;

AGED; ALLOPURINOL; EPIDERMAL NECROLYSIS, TOXIC; FATAL OUTCOME; FEMALE; GOUT SUPPRESSANTS; HUMANS; MULTIPLE ORGAN FAILURE; STEVENS-JOHNSON SYNDROME;

EID: 77951099846     PISSN: 00221198     EISSN: 15564029     Source Type: Journal    
DOI: 10.1111/j.1556-4029.2010.01338.x     Document Type: Article

References (37)

1. Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 1956 68 (11 355 361.
2. Becker DS. Toxic epidermal necrolysis. The Lancet 1998 351 (9113 1417 1420. (Pubitemid 28210009)
3. Jongen-Lavrencic M, Schneeberger PM, van der Hoeven JG. Ciprofloxacin-induced toxic epidermal necrolysis in a patient with systemic lupus erythematosus. Infection 2003 31 (6 428 429. (Pubitemid 38005375)
4. Aguiar D, Pazo R, Duran I, Terrasa J, Arrivi A, Manzano H, et al. Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J Neurooncol 2004 66 (3 345 350. (Pubitemid 38258350)
5. Mermershtain W, Cohen AD, Lazarev I, Grunwald M, Ariad S. Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder. J Chemother 2003 15 (5 510 511. (Pubitemid 37330580)
6. Hockett KC. Stevens-Johnson syndrome and toxic epidermal necrolysis: oncologic considerations. Clin J Oncol Nurs 2004 8 (1 27 30.
7. Ikeda N, Umetsu K, Suzuki T. A fatal case of sulindac-induced Lyell syndrome (toxic epidermal necrolysis). Z Rechtsmed 1987 98 (2 141 146. (Pubitemid 17115118)
8. Layton D, Marshall V, Boshier A, Friedmann P, Shakir SA. Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England. Drug Saf 2006 29 (8 687 696. (Pubitemid 44175039)
9. Rougeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995 333 : 1600 1607.
10. Caumes E, Bossi P, Katlama C, Bricaire F. Antiretroviral-induced toxiderma in HIV-infected patients. Presse Med 2003 32 : 1325 1333.
11. Leone R, Venegoni M, Motola D, Moretti U, Piazzetta V, Cocci A, et al. Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three Italian regions. Drug Saf 2003 26 : 109 120.
12. Dan M, Jedwab M, Peled M, Shibolet S. Allopurinol-induced toxic epidermal necrolysis. Int J Dermatol 1984 23 (2 142 144.
13. Auböck J, Fritsch P. Asymptomatic hyperuricaemia and allopurinol induced toxic epidermal necrolysis. Br Med J (Clin Res Ed) 1985 290 (6486 1969 1970.
14. Renwick IG. Asymptomatic hyperuricaemia and allopurinol induced toxic epidermal necrolysis. Br Med J (Clin Res Ed) 1985 291 (6493 485.
15. Coutellier P, Delgrange B. Fatal toxic epidermolysis following administration of allopurinol. Acta Clin Belg 1989 44 (3 196 198.
16. Hammer B, Link A, Wagner A, Böhm M. Hypersensitivity syndrome during therapy with allopurinol in asymptomatic hyperuricemia with a fatal outcome. Dtsch Med Wochenschr 2001 126 (47 1331 1334.
17. Saxena R, Loghmanee F. Fatal drug reaction due to allopurinol therapy in a 72-year-old man. Arch Pathol Laborat Med 2005 129 (8 183 184.
18. Gutierrez-Macias A, Lizarralde-Palacios E, Martinez-Odriozola P, Miguel-De la Villa F. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia. BMJ 2005 17 (331 623 624.
19. Dainichi T, Uchi H, Moroi Y, Furue M. Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele; what causes the diversity? Dermatology 2007 215 (1 86 8.
20. Fagugli RM, Gentile G, Ferrara G, Brugnano R. Acute renal and hepatic failure associated with allopurinol treatment. Clin Nephrol 2008 70 (6 523 526.
21. Lee HY, Pang SM, Thamotharampillai T. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis. J Am Acad Dermatol 2008 59 (2 352 353.
22. Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A, et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 2008 58 (1 25 32.
23. Revuz J, Penso D, Roujeau JC, Guillaume JC, Payne CR, Wechsler J, et al. Toxic epidermal necrolysis: clinical findings and prognostic factors in 87 patients. Arch Dermatol 1987 123 : 1160 1165.
24. Revuz J, Roujeau JC, Guillaume JC, Penso D, Touraine R. Treatment of toxic epidermal necrolysis. Creteil's experience. Arch Dermatol 1987 123 : 1156 1158. (Pubitemid 17119308)
25. Pereira FA, Mudgil AV, Rosmarin DM. Toxic epidermal necrolysis. J Am Acad Dermatol 2007 56 (2 181 200.
26. Sugimoto Y, Mizutami H, Sato T, Kawamura N, Ohkouchi K, Shimizu M. Toxic epidermal necrolysis with severe gastrointestinal mucosal cell death: a patient who excreted long tubes of dead intestinal epithelium. J Dermatol 1998 25 : 533 538.
27. Lebargy F, Wolkenstein P, Gisselbrecht M, Lange F, Fleury-Feith J, Delclaux C, et al. Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med 1997 23 : 1237 1244.
28. Wolkenstein P, Revuz J. Toxic epidermal necrolysis. Dermatol Clin 2000 18 : 485 495.
29. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 2000 115 : 149 153.
30. French LE. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int 2006 55 (1 9 16.
31. Khalili B, Bahna SL. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Ann Allergy Asthma Immunol 2006 97 (3 272 280.
32. Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 2002 8 : 5.
33. Quinn AM, Brown K, Bonish BK, Curry J, Gordon KB, Sinacore J, et al. Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis. Arch Dermatol 2005 141 : 683 687.
34. Timperman J, Verbauwhede W. Toxic Epidermal Necrolysis (Lyell Syndrome) and its medico-legal implications. Z Rechtsmed 1972 71 : 139 144.
35. Metter D, Schulz E. Tödliche Verbrühung oder Lyell-Syndrom? Z Rechtsmed 1978 81 : 329 334.
36. Mockenhaupt M, Idzko M, Grosber M, Schöpf E, Norgauer J. Epidemiology of staphylococcal scalded skin syndrome in Germany. J Invest Dermatol 2005 124 : 700 703.
37. Tschachler E, Brockmeyer N, Effendy I, Geiss HK, Harder S, Hartmann M, et al. Streptococcal infections of the skin and mucous membranes. J Dtsch Dermatol Ges 2007 5 (6 527 532.